2,4-dimethoxybenzaldehyde
Names
[ CAS No. ]:
613-45-6
[ Name ]:
2,4-dimethoxybenzaldehyde
[Synonym ]:
VHR BO1 DO1
4,6-dimethoxybenzaldehyde
Benzaldehyde,2,4-dimethoxy
EINECS 210-342-4
2,4-dimethoxyphenylbenzaldehyde
MFCD00003311
2,4-dimethoxybenzaldehyde
2,4,7-TRIMETHYL-1H-INDOLE-3-CARBALDEHYDE
Benzaldehyde, 2,4-dimethoxy-
Chemical & Physical Properties
[ Density]:
1.1±0.1 g/cm3
[ Boiling Point ]:
307.8±0.0 °C at 760 mmHg
[ Melting Point ]:
67-69 °C(lit.)
[ Molecular Formula ]:
C9H10O3
[ Molecular Weight ]:
166.174
[ Flash Point ]:
124.7±8.2 °C
[ Exact Mass ]:
166.062988
[ PSA ]:
35.53000
[ LogP ]:
1.66
[ Vapour Pressure ]:
0.0±0.6 mmHg at 25°C
[ Index of Refraction ]:
1.534
[ Storage condition ]:
2-8°C
[ Water Solubility ]:
insoluble
MSDS
Safety Information
[ Symbol ]:
GHS07
[ Signal Word ]:
Warning
[ Hazard Statements ]:
H315-H319-H335
[ Precautionary Statements ]:
P261-P305 + P351 + P338
[ Personal Protective Equipment ]:
dust mask type N95 (US);Eyeshields;Gloves
[ Hazard Codes ]:
Xi:Irritant
[ Risk Phrases ]:
R36/37/38
[ Safety Phrases ]:
S26-S36-S24/25
[ RIDADR ]:
NONH for all modes of transport
[ WGK Germany ]:
3
[ HS Code ]:
29124900
Synthetic Route
Precursor & DownStream
Precursor
DownStream
Customs
[ HS Code ]: 2912499000
[ Summary ]:
2912499000. other aldehyde-ethers, aldehyde-phenols and aldehydes with other oxygen function. VAT:17.0%. Tax rebate rate:9.0%. . MFN tariff:5.5%. General tariff:30.0%
Articles
Ann. Clin. Microbiol. Antimicrob. 10 , 23, (2011)
Disruption of cellular antioxidation systems should be an effective method for control of fungal pathogens. Such disruption can be achieved with redox-active compounds. Natural phenolic compounds can ...
Rational design of inhibitors of VirA-VirG two-component signal transduction.Bioorg. Med. Chem. Lett. 17 , 3281-6, (2007)
VirA-VirG two-component system regulates the vir (virulence) operon in response to specific host factors (xenognosins) in the plant pathogen Agrobacterium tumefaciens. Using whole cell assays, stable ...
Can phlorotannins purified extracts constitute a novel pharmacological alternative for microbial infections with associated inflammatory conditions?PLoS ONE 7(2) , e31145, (2012)
Bacterial and fungal infections and the emerging multidrug resistance are driving interest in fighting these microorganisms with natural products, which have generally been considered complementary to...